Company Filing History:
Years Active: 2019-2021
Title: Innovations by Melissa Jane Birch
Introduction
Melissa Jane Birch is a notable inventor based in Sandwich, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for abnormal cell growth, including cancer. With a total of 2 patents, her work is recognized for its potential impact on medical science.
Latest Patents
Birch's latest patents include a crystalline form of lorlatinib free base, specifically Form 7. This invention relates to a crystalline form of (10R)-7-amino-12-fluoro-2,10,16-trimethyl-5-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclo-tetradecine-3-carbonitrile (lorlatinib) free base. The invention also encompasses pharmaceutical compositions comprising Form 7 and methods of using Form 7 and such compositions in the treatment of abnormal cell growth, such as cancer, in mammals.
Career Highlights
Melissa Jane Birch is currently associated with Pfizer Corporation, a leading global pharmaceutical company. Her work at Pfizer has allowed her to focus on innovative solutions that address critical health challenges. Birch's contributions are vital in advancing the understanding and treatment of various medical conditions.
Collaborations
Some of her notable coworkers include Klimentina Dimitrova Pencheva and Stephen Mark McAllister. Their collaborative efforts contribute to the success of the projects they undertake together.
Conclusion
Melissa Jane Birch's innovative work in the pharmaceutical industry highlights her commitment to improving health outcomes through her inventions. Her contributions, particularly in the development of treatments for cancer, underscore the importance of research and innovation in medicine.